Cargando…
Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
Ammonium tetrathiomolybdate (ATTM) has been used in breast cancer therapy for copper chelation, as elevated copper promotes tumor growth. ATTM is also an identified H(2)S donor and endogenous H(2)S facilitates VitB(12)-induced S-adenosylmethionine (SAM) generation, which have been confirmed in m(6)A...
Autores principales: | Li, Xiang, Li, Na, Huang, Li, Xu, Shi, Zheng, Xue, Hamsath, Akil, Zhang, Mei, Dai, Lijun, Zhang, Hui, Wong, Justin Jong-Leong, Xian, Ming, Yang, Chun-tao, Liu, Jinbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061217/ https://www.ncbi.nlm.nih.gov/pubmed/32195181 http://dx.doi.org/10.3389/fonc.2020.00234 |
Ejemplares similares
-
Ammonium tetrathiomolybdate treatment of copper‐associated hepatopathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2019) -
Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
por: Mendonça, Bruna Pescador, et al.
Publicado: (2020) -
Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells
por: Zhang, Mengling, et al.
Publicado: (2022) -
Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models
por: Dyson, Alex, et al.
Publicado: (2017) -
Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway
por: Qi, Hao, et al.
Publicado: (2023)